[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100619572":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":51,"collaborators":55,"id":89,"slug":90,"hasResults":91,"nctId":92,"briefTitle":93,"officialTitle":94,"acronym":95,"eligibilityCriteria":96,"healthyVolunteers":91,"sex":97,"minAge":98,"maxAge":26,"enrollmentInfo":99,"targetDuration":26,"studyType":102,"phases":103,"briefSummary":105,"conditions":106,"keywords":112,"overallStatus":119,"whyStopped":26,"lastUpdateSubmitDate":120,"lastUpdatePostDateStruct":121,"startDateStruct":124,"completionDateStruct":126,"leadSponsor":128,"locationsCount":129},{"fullName":5,"class":6},"Johann Wolfgang Goethe University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard","ACTIVE_COMPARATOR","Standard time of the removal",[13],"Device: standard group",{"label":15,"type":16,"description":17,"interventionNames":18},"Interventional - delayed removal","EXPERIMENTAL","Stent removal after 1 - 3 months",[19],"Device: pancreatic stent removal",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DEVICE","pancreatic stent removal","Removal of the pancreatic stent after 1 - 3 months after the placement",[15],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"standard group","Removal at intervals of 12 hours up to a maximum of 10 days after the index ERCP",[9],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Florian Michael, Dr. med.","CONTACT","004915117191302","Fmichael@med.uni-frankfurt.de",[38],{"facility":39,"status":26,"city":40,"state":26,"zip":26,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Johann Wolfgang Goethe-Universität Frankfurt am Main","Frankfurt","Germany","DE",{"type":44,"coordinates":45},"Point",[46,47],10.53333,49.68333,{"lat":47,"lon":46},[50],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},{"type":52,"investigatorFullName":53,"investigatorTitle":54,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Georg Dultz","Senior Physician at Clinic of Gastroenterology, Johann Wolfgang Goethe University Hospital",[56,58,60,63,65,67,69,71,73,75,77,79,81,83,85,87],{"name":57,"class":6},"SRH Wald-Klinikum Gera GmbH",{"name":59,"class":6},"Asklepios Kliniken Hamburg GmbH",{"name":61,"class":62},"Charité - Universitätsmedizin Berlin, Campus Virchow Klinikum","UNKNOWN",{"name":64,"class":62},"Helios Klinikum Krefeld",{"name":66,"class":6},"Sana Klinikum Offenbach",{"name":68,"class":6},"St. Josef Hospital Bochum",{"name":70,"class":6},"University Hospital, Aachen",{"name":72,"class":6},"University Hospital, Essen",{"name":74,"class":6},"University Hospital Freiburg",{"name":76,"class":62},"Münster University Hospital, Germany",{"name":78,"class":62},"Medizinische Universitätsklinik Tübingen",{"name":80,"class":6},"University of Göttingen",{"name":82,"class":6},"University Hospital, Basel, Switzerland",{"name":84,"class":62},"Centrum Gastroenterologie Bethanien",{"name":86,"class":6},"University Hospital Munich",{"name":88,"class":6},"University of Wuerzburg","100619572","spontaneous-dislocation-and-adverse-events-of-a-prophylactic-pancreatic-stent-100619572",false,"NCT07346365","Spontaneous Dislocation and Adverse Events of a Prophylactic Pancreatic Stent","Spontaneous Dislocation and Adverse Events of a Prophylactic Pancreatic Stent: a Prospective, Randomised, Multicenter Study (SAFE PANCREAS)","SAFE PANCREAS","Inclusion Criteria:\n\n* prophylactic pancreatic stent (5Fr 4cm length)\n* informed consent\n\nExclusion Criteria:\n\n* necrotising post-ercp-pancreatitis\n* pregnancy\u002Fbreastfeeding\n* Billroth II","ALL","18 Years",{"count":100,"type":101},358,"ESTIMATED","INTERVENTIONAL",[104],"NA","A multicenter, prospective, controlled randomized study to investigate the optimal duration of protective pancreatic stents after endoscopic retrograde cholangiopancreatography (ERCP).\n\nThe primary endpoint is the complication rate that can be clinically attributed to the remaining pancreatic prosthesis or its removal in the study groups. Secondary endpoints are spontaneous removal of the pancreatic stent, length of hospital stay, rate of follow-up examinations per group, influencing factors, and a possible exploratory analysis.",[107,108,109,110,111],"Stent Dislodgement","ERCP","Pancreas Stent","Post-ERCP Pancreatitis","Prophylactic Pancreatic Stent",[113,114,115,116,117,118],"ercp","prophylactic pancreatic stent","post-ercp-pancreatitis","pancreatic stent","post-ercp pancreatitis","PEP","NOT_YET_RECRUITING","2026-01-14",{"date":122,"type":123},"2026-01-16","ACTUAL",{"date":125,"type":101},"2026-01-01",{"date":127,"type":101},"2032-06",{"name":5,"class":6},1]